Ricardo S - Search Results

1

Enhancing Immunotherapy in Ovarian Cancer: The Emerging Role of Metformin and Statins.

Almeida-Nunes DL, Silvestre R, Dinis-Oliveira RJ, Ricardo S. Almeida-Nunes DL, et al. Among authors: ricardo s. Int J Mol Sci. 2023 Dec 25;25(1):323. doi: 10.3390/ijms25010323. Int J Mol Sci. 2023. PMID: 38203494 Free PMC article. Review.

2

Recycling the Purpose of Old Drugs to Treat Ovarian Cancer.

Nunes M, Henriques Abreu M, Bartosch C, Ricardo S. Nunes M, et al. Among authors: ricardo s. Int J Mol Sci. 2020 Oct 20;21(20):7768. doi: 10.3390/ijms21207768. Int J Mol Sci. 2020. PMID: 33092251 Free PMC article. Review.

3

Mesothelin Expression Is Not Associated with the Presence of Cancer Stem Cell Markers SOX2 and ALDH1 in Ovarian Cancer.

Nunes M, Pacheco F, Coelho R, Leitão D, Ricardo S, David L. Nunes M, et al. Among authors: ricardo s. Int J Mol Sci. 2022 Jan 18;23(3):1016. doi: 10.3390/ijms23031016. Int J Mol Sci. 2022. PMID: 35162954 Free PMC article.

4

Immune Tumor Microenvironment in Ovarian Cancer Ascites.

Almeida-Nunes DL, Mendes-Frias A, Silvestre R, Dinis-Oliveira RJ, Ricardo S. Almeida-Nunes DL, et al. Among authors: ricardo s. Int J Mol Sci. 2022 Sep 14;23(18):10692. doi: 10.3390/ijms231810692. Int J Mol Sci. 2022. PMID: 36142615 Free PMC article. Review.

5

The Antineoplastic Effect of Carboplatin Is Potentiated by Combination with Pitavastatin or Metformin in a Chemoresistant High-Grade Serous Carcinoma Cell Line.

Nunes M, Duarte D, Vale N, Ricardo S. Nunes M, et al. Among authors: ricardo s. Int J Mol Sci. 2022 Dec 21;24(1):97. doi: 10.3390/ijms24010097. Int J Mol Sci. 2022. PMID: 36613537 Free PMC article.

6

Deciphering the Molecular Mechanisms behind Drug Resistance in Ovarian Cancer to Unlock Efficient Treatment Options.

Nunes M, Bartosch C, Abreu MH, Richardson A, Almeida R, Ricardo S. Nunes M, et al. Among authors: ricardo s. Cells. 2024 May 4;13(9):786. doi: 10.3390/cells13090786. Cells. 2024. PMID: 38727322 Free PMC article. Review.

7

Peritoneal dissemination of ovarian cancer: role of MUC16-mesothelin interaction and implications for treatment.

Coelho R, Marcos-Silva L, Ricardo S, Ponte F, Costa A, Lopes JM, David L. Coelho R, et al. Among authors: ricardo s. Expert Rev Anticancer Ther. 2018 Feb;18(2):177-186. doi: 10.1080/14737140.2018.1418326. Epub 2017 Dec 21. Expert Rev Anticancer Ther. 2018. PMID: 29241375 Review.

8

Mucins and Truncated O-Glycans Unveil Phenotypic Discrepancies between Serous Ovarian Cancer Cell Lines and Primary Tumours.

Coelho R, Marcos-Silva L, Mendes N, Pereira D, Brito C, Jacob F, Steentoft C, Mandel U, Clausen H, David L, Ricardo S. Coelho R, et al. Among authors: ricardo s. Int J Mol Sci. 2018 Jul 13;19(7):2045. doi: 10.3390/ijms19072045. Int J Mol Sci. 2018. PMID: 30011875 Free PMC article.

9

Regulation of invasion and peritoneal dissemination of ovarian cancer by mesothelin manipulation.

Coelho R, Ricardo S, Amaral AL, Huang YL, Nunes M, Neves JP, Mendes N, López MN, Bartosch C, Ferreira V, Portugal R, Lopes JM, Almeida R, Heinzelmann-Schwarz V, Jacob F, David L. Coelho R, et al. Among authors: ricardo s. Oncogenesis. 2020 Jul 1;9(6):61. doi: 10.1038/s41389-020-00246-2. Oncogenesis. 2020. PMID: 32612258 Free PMC article.

10

Generation of Two Paclitaxel-Resistant High-Grade Serous Carcinoma Cell Lines With Increased Expression of P-Glycoprotein.

Nunes M, Silva PMA, Coelho R, Pinto C, Resende A, Bousbaa H, Almeida GM, Ricardo S. Nunes M, et al. Among authors: ricardo s. Front Oncol. 2021 Oct 21;11:752127. doi: 10.3389/fonc.2021.752127. eCollection 2021. Front Oncol. 2021. PMID: 34745981 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

182 results

Search Page